Tech firms face more regulation after moves to stop 'killer' acquisitions – but innovation could also be under threat

By Renaud Foucart, Senior Lecturer in Economics, Lancaster University Management School, Lancaster University

One way to eliminate the competition in business is simply to buy them out and shut them down. And that means less choice for consumers and sometimes the loss of innovative and, in the case of the pharmaceutical industry, even life-saving products. But such so-called killer acquisitions are likely to face greater scrutiny in the US and EU following a recent expansion of competition regulators’ powers.

A July 2022 decision by the European Court of Justice has expanded…

Read complete article

~	Lebanon: Ministerial Decision Advances Justice

~	Global: UN Special Rapporteur is right to raise human rights concerns about carbon markets

~	On X, Elon Musk pushes a campaign against a Brazilian Supreme Court Justice

~	US Universities Should Respect Right to Protest

~	Burkina Faso: UN rights office deeply alarmed at reported killing of 220 villagers

~	A new dash for copper is underway - how will it play out? Expert Q&A

~	Why does it feel so cold in the UK right now – and when will it warm up?

~	Artificial sweetener could harm your gut and the microbes that live there – new study

~	Gaza war: ‘no evidence’ of Hamas infiltration of UN aid agency, says report – but US and UK dither on funding while famine takes hold

~	Five books by Maryse Condé to introduce you to the award-winning Guadeloupian writer